Effective Pharmacovigilance System Development: EFPIA-IPVG Consensus Recommendations

被引:10
|
作者
Peters, Tanja [1 ]
Soanes, Nigel [2 ]
Abbas, Maya [3 ]
Ahmad, Jabeen [4 ]
Delumeau, Jean-Christophe [5 ]
Herrero-Martinez, Esteban [6 ]
Paramananda, Melanie [7 ]
Piper, Johanna [8 ]
Smail-Aoudia, Fairouz [7 ]
van der Spuij, Willemijn [9 ]
Veizovic, Tina [10 ]
Winstanley, Gillian [11 ]
机构
[1] Boehringer Ingelheim GmbH & Co KG, Ingelheim, Germany
[2] AstraZeneca PLC, Cambridge, England
[3] Johnson & Johnson Middle East, Beirut, Lebanon
[4] Innovate PV, London, England
[5] Bayer Pharma, Singapore, Singapore
[6] AbbVie Ltd, Maidenhead, Berks, England
[7] Pierre Fabre Medicament, Boulogne, France
[8] Roche Prod Ltd, Welwyn Garden City, Herts, England
[9] Bristol Myers Squibb, Steinhausen, Switzerland
[10] Takeda, London, England
[11] Amgen Canada Inc, Mississauga, ON, Canada
关键词
D O I
10.1007/s40264-020-01008-0
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Pharmaceutical legislation provides a legal framework to ensure the safe and effective use of medicines. This framework requires national regulatory authorities (NRAs) to establish and maintain a pharmacovigilance system (PV system) stating and enforcing the regulatory commitments that key stakeholders, including marketing authorisation holders (MAHs), are required to fulfil. In recent years, national legislative bodies and NRAs across the world have issued a significant amount of legislation and guidance enforcing the obligation to perform pharmacovigilance activities. In countries where the NRA is a member of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), safety management requirements are generally consistent with ICH guidelines. In a number of countries beyond this scope, requirements may deviate from internationally agreed standards, adding a substantial complexity and increasing burden on the stakeholders involved, whilst the benefit for patients' safety may not be evident. Committed to fulfilling safety-regulatory obligations in any country where a product licence is held, global pharmaceutical companies have accumulated a broad and deep experience acquired whilst meeting the expectations of a large array of diverse PV systems across the world. These range from sub-optimal frameworks, according to the World Health Organization (WHO) Global Benchmarking Tool, to highly effective resource-optimised PV systems. In order to support countries creating or further developing their PV systems, especially where infrastructure and resources are limited, the European Federation of Pharmaceutical Industries and Associations (EFPIA) International Pharmacovigilance Group (IPVG) has developed consensus recommendations consistent with harmonised standards for the development and step-wise implementation of key PV system components. These recommendations endorsed by the EFPIA membership constitute the focus of this review article.
引用
收藏
页码:17 / 28
页数:12
相关论文
共 50 条
  • [22] Teenage Development and Parental Authority: applying consensus recommendations to adolescent care
    Ross, Lainie Friedman
    Hester, D. Micah
    Malone, Jay R.
    PERSPECTIVES IN BIOLOGY AND MEDICINE, 2024, 67 (02) : 227 - 243
  • [23] Development of psycho-oncology telehealth recommendations: A Delphi consensus study
    Cooper, Claire
    Gilchrist, Jemma
    Beatty, Lisa
    Kirsten, Laura
    Sharpe, Louise
    Zomerdijk, Nienke
    Grier, Maree
    Turner, Jane
    Hobbs, Kim
    Haydon, Helen
    Dhillon, Haryana
    Kelly, Brian
    Shaw, Joanne
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 : 119 - 120
  • [24] Development of Mobile System for Medical Recommendations
    Shakhovska, Nataliya
    Fedushko, Solomiia
    Ml, Michal Gregus
    Shvorob, Iryna
    Syerov, Yuriy
    16TH INTERNATIONAL CONFERENCE ON MOBILE SYSTEMS AND PERVASIVE COMPUTING (MOBISPC 2019),THE 14TH INTERNATIONAL CONFERENCE ON FUTURE NETWORKS AND COMMUNICATIONS (FNC-2019),THE 9TH INTERNATIONAL CONFERENCE ON SUSTAINABLE ENERGY INFORMATION TECHNOLOGY, 2019, 155 : 43 - 50
  • [25] Barriers and new opportunities in developing effective therapies for diabetic neuropathy: International expert consensus recommendations
    Brock, C.
    Andersen, H.
    Alibegovic, A. C.
    Andersen, S. T.
    Andreasen, L. J.
    Charles, M. H.
    Christensen, D. H.
    Drewes, A. M.
    Gall, M. -a
    Gylfadottir, S. S.
    Hansen, C. S.
    Hecquet, S. K.
    Jensen, T. S.
    Karlsson, P.
    Knudsen, L. B.
    Lobato, C. B.
    Kufaishi, H.
    Maalmi, H.
    Mizrak, H., I
    Nilsen, K. B.
    Perkins, B. A.
    Roikjer, J.
    Rossing, P.
    Rungby, J.
    Romer, J.
    Stouge, A.
    Sulek, K.
    Softeland, E.
    Tahrani, A. A.
    Terkelsen, A. J.
    Tesfaye, S.
    Wegeberg, A.
    Akerstrom, T.
    Brock, B.
    Pop-Busui, R.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2025, 221
  • [26] Development of Consensus Recommendations on the Management of Vitiligo and the Role of Decapeptide in Vitiligo by the Delphi Method
    Parsad, Davinder
    Kandhari, Sanjeev
    Dhurat, Rachita
    Shah, Bela
    Majid, Imran
    Yadalla, Harikishan Kumar
    Sakhiya, Jagdish
    Poojary, Shital
    Jagadish, P.
    Banotkar, Pravin D.
    Babu, Ravindra
    Shivakumar, Y. M.
    Bose, S. K.
    Jamadar, Saleem
    Shah, Monal
    Tank, Bharat
    Dhabhai, Ravindra
    Mittal, Sanjay Kumar
    Bhushan, Premanshu
    Pandita, Akshi
    Barve, Vaibhav
    INDIAN JOURNAL OF DERMATOLOGY, 2023, 68 (05) : 587
  • [27] Development of national consensus recommendations for the management of colchicine poisoning by Poisons Information Centers
    Roberts, Darren
    Wong, Anselm
    Vlad, Ioana
    Brown, Jared
    Nguyen, Elizabeth
    Dawson, Andrew
    CLINICAL TOXICOLOGY, 2018, 56 (10) : 1028 - 1029
  • [28] Development of Evidence-based Recommendations: Implications for Preparing Expert Consensus Statements
    Kwong Joey S W
    Chen Hao
    Sun Xin
    Chinese Evidencebased Medicine Center and Chinese Cochrane Center West China Hospital Sichuan University Chengdu Sichuan China
    The Second Clinical College Nanjing University of Chinese Medicine Nanjing Jiangsu China
    中华医学杂志英文版, 2016, 129 (24) : 2998 - 3000
  • [29] International consensus recommendations on the diagnostic work-up for malformations of cortical development
    Oegema, Renske
    Barakat, Tahsin Stefan
    Wilke, Martina
    Stouffs, Katrien
    Amrom, Dina
    Aronica, Eleonora
    Bahi-Buisson, Nadia
    Conti, Valerio
    Fry, Andrew E.
    Geis, Tobias
    Gomez Andres, David
    Parrini, Elena
    Pogledic, Ivana
    Said, Edith
    Soler, Doriette
    Valor, Luis M.
    Zaki, Maha S.
    Mirzaa, Ghayda
    Dobyns, William B.
    Reiner, Orly
    Guerrini, Renzo
    Pilz, Daniela T.
    Hehr, Ute
    Leventer, Richard J.
    Jansen, Anna C.
    Mancini, Grazia M. S.
    Di Donato, Nataliya
    NATURE REVIEWS NEUROLOGY, 2020, 16 (11) : 618 - 635
  • [30] International consensus recommendations on the diagnostic work-up for malformations of cortical development
    Renske Oegema
    Tahsin Stefan Barakat
    Martina Wilke
    Katrien Stouffs
    Dina Amrom
    Eleonora Aronica
    Nadia Bahi-Buisson
    Valerio Conti
    Andrew E. Fry
    Tobias Geis
    David Gomez Andres
    Elena Parrini
    Ivana Pogledic
    Edith Said
    Doriette Soler
    Luis M. Valor
    Maha S. Zaki
    Ghayda Mirzaa
    William B. Dobyns
    Orly Reiner
    Renzo Guerrini
    Daniela T. Pilz
    Ute Hehr
    Richard J. Leventer
    Anna C. Jansen
    Grazia M. S. Mancini
    Nataliya Di Donato
    Nature Reviews Neurology, 2020, 16 : 618 - 635